Viewing Study NCT03188666


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2025-12-25 @ 2:12 PM
Study NCT ID: NCT03188666
Status: COMPLETED
Last Update Posted: 2022-12-02
First Post: 2017-06-13
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva
Sponsor: Regeneron Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: R2477-FOP-1623
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators